Skip to content

Treatment for Sthaulya (obesity) by Panchakarma (Basti and Virechana)

A comparative clinical study to evaluate the role of Lekhana basti and Virechana karma in Sthaulya (obesity). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081999
Enrollment
30
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Department of Panchakarma Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pateints with BMI more than or equal to 25 and less than 40

Exclusion criteria

Exclusion criteria: The patient having B.M.I. more than 40 kg/m2 FOR GROUP A Patients contraindicated for Basti karma like, Udara rog, intestinal perforation, intestinal obstruction, Pregnant and lactating women. FOR GROUP B Patients contraindicated for virechana karma like Rectal prolapse, lower GI bleeding, Incontinence of stool. Patients with renal (Sr. creatinine more than 1.8mg/dl and Sr. Urea more than 60 mg/dl,) or hepatic impairment (SGOT and SGPT more than Five times of upper limit) Patients with Blood pressure in the range of more than or equal to 160/100mm of Hg) or more, Diabetes Mellitus (having HbA1c more than 7 % with or without hyperglycemic medications. Known case of IHD, CAD, CHF or other major cardiovascular problems will not be included for this study. Patients on anti-tubercular, anti-retroviral, antibiotic medications. Patients requiring emergency treatment

Design outcomes

Primary

MeasureTime frame
The proportion of patients showing reduction in BMI, Girth measurements and Skin folds thickness of post lekhana Basti karma and Virechan karma. Timepoint: Day 0 (group A and B)- subjective and objective parameters will be assessed. Vitals examination, CBC, HbA1c, LFT, KFT and Lipid Profile will be done. In Group A after lekhana basti and In Group B after virechana Vitals examination, Subjective and Objective Parameters will be assessed. On Day 30th - (group A & B) Vitals examination, Subjective and Objective Parameters will be assessed. CBC, HbA1c, LFT, KFT and Lipid Profile will be done.

Secondary

MeasureTime frame
The proportion of patients showing changes in the serum leptin post lekhana Basti karma & Virechan karma. The proportion of patients showing changes in the gut microbiome post lekhana Basti karma & Virechan karma. Timepoint: Day 0 ( both group A & B ) serum leptin , gut microbiome for 10 pateints After lekhana basti & virechana Day 16th gut microbiome (5 pateints) for group A After 1st day of virechana gut microbiome (5 pateints) for group B Day 30th both group A & B serum leptin

Countries

India

Contacts

Public ContactJolly Gautam

Ayurvedic and Unani Tibbia college and hospital ,Karol Bagh New Delhi

manojshamkuwar@gmail.com9354925019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026